AACR 2023
Experts from Fred Hutchinson Cancer Center will share their latest findings in cellular immunotherapy, early detection cancer screening tests, interplays between the microbiome and genetics in colorectal cancer and more at the 2023 American Association for Cancer Research (AACR) Annual Meeting.
The theme of the 2023 AACR annual meeting is: Advancing the Frontiers of Cancer Science and Medicine.
Featured Events
Educational Session
How can we realize the promise of novel technologies for early cancer detection?
Presenter: Ruth Etzioni, Ph.D.
Presentation: Developing realistic expectations for new cancer screening tests
Friday, April 14, 2023, 3:01 p.m. - 3:21 p.m. (ET)
Major Symposium
Targeting RNA splicing in cancer and the immune system
Presenter: Robert Bradley, Ph.D. (On Twitter)
Presentation: From splicing to polyadenylation in tumor immunity
Sunday, April 16, 2023, 1:55 p.m. - 2:15 p.m. (ET)
Meet the Expert
Presenter: Christopher Li, M.D., Ph.D. (On LinkedIn)
Tuesday, April 18, 2023, 7 a.m. - 7:45 a.m. (ET)
Meet the President
Meet the 2023-2024 AACR President, Philip Greenberg
Philip Greenberg, M.D., currently president-elect of AACR, will become AACR president during the meeting. He leads the Program in Immunology at Fred Hutch and holds the Rona Jaffe Foundation Endowed Chair.
April 18, 2023, 1:30 p.m. - 2:30 p.m. (ET)
More Highlights of Fred Hutch Presentations at AACR
Friday, April 14 | Saturday, April 15 | Sunday, April 16 | Monday, April 17 | Tuesday, April 18 | Wednesday, April 19
Studying tumor dormancy and metastasis in immune-competent settings
Presenter: Cyrus Ghajar, Ph.D. (Educational session)
Friday, April 14, 5:15 p.m - 5:35 p.m. (ET)
A geospatial guide for integrating location into cancer population sciences research
Presenter: Trang VoPham, Ph.D., MPH, M.S. (Methods workshop)
Saturday, April 15, 2:35 p.m. - 3:05 p.m. (ET)
Intra and inter-tumor heterogeneity across cancer metastases: A reality check for targeted therapeutics and the utility of non-invasive biomarkers
Presenter: Peter Nelson, M.D. (Educational Session)
Saturday, April 15, 2023, 3:16 p.m. - 3:33 p.m. (ET)
Genetically engineered anticancer T cells
Presenter: Sam Nutt (Mini symposium)
Sunday, April 16, 4:10 p.m. - 4:25 p.m. (ET)
Measuring and modulating SCLC transcriptional heterogeneity from murine models to clinical trials
Presenter: Joseph Hiatt M.D., Ph.D. (Session: Advances in Organ Site Research)
Monday, April 17, 1 p.m. - 1:20 p.m. (ET)
Association between HLA-KIR allele interaction combinations and density of T-cell subsets in colorectal cancer
Presenter: Claire E. Thomas, Ph.D., MPH (Poster)
Monday, April 17, 2023, 1:30 p.m. - 5 p.m.
Evaluation of intra-tumoral pks+ E. coli, enterotoxigenic B. fragilis and Fusobacterium nucleatum and in early onset disease, in colorectal cancer cases
Presenter: Meredith Hullar, Ph.D. (Poster)
Monday, April 17, 2023, 1:30 p.m. - 5 p.m.
Interrogating cancer risk with germline genetics and other multi-omic data
Presenter: Burcu Darst, Ph.D. (Session: Advances in Population Science)
Monday, April 17, 12:35 p.m. - 12:55 p.m. (ET)
Protein-level regulation of wild-type and mutant RIT1 by the deubiquitinase USP9X
Presenter: Amanda Riley B.S. (Poster)
Monday, April 17, 1:30 p.m. - 5 p.m. (ET)
Sex differences in severe adverse events in patients receiving immunotherapy, targeted therapy, or chemotherapy in Cancer clinical trials: An evidentiary perspective
Presenter: Joseph Unger, Ph.D., M.S. (Session: Sex hormones and cancer)
Tuesday, April 18, 1:25 p.m. - 1:45 p.m. (ET)
Lifestyle and environmental factors in relation to colorectal cancer risk and survival by colibactin tumor mutational signature status
Presenter: Claire E. Thomas, Ph.D., MPH (Poster)
Wednesday, April 19, 2023, 9 a.m. - 12:30 p.m. (ET)
Biomarker analysis from AMPECT correlating response to nab-sirolimus with TSC1 and TSC2 inactivating alterations
Presenter: Lee Cranmer, M.D., Ph.D., F.A.C.P. (Late-Breaking Poster Session)
Wednesday, April 19, 9 a.m. - 12:30 p.m. (ET)
Contact Our Media Relations Team
For more information or to arrange an interview, please email or call our media relations team.